Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Glucagon like peptide-1 (GLP-1) agonists Market Research Report 2016

  • QYR673329
  • 104 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Production, means the output of Glucagon like peptide-1 (GLP-1) agonists

Revenue, means the sales value of Glucagon like peptide-1 (GLP-1) agonists

This report studies Glucagon like peptide-1 (GLP-1) agonists in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

Novo Nordisk

AstraZeneca

Eli Lilly

GSK

Sanofi

Bristol-Myers Squibb

Amylin

...

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Glucagon like peptide-1 (GLP-1) agonists in these regions, from 2011 to 2021 (forecast), like

North America

Europe

China

Japan

Southeast Asia

India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

Exenatied

Liraglutide

Lixisenatide

Abliglutide

Dulaglutide

Split by application, this report focuses on consumption, market share and growth rate of Glucagon like peptide-1 (GLP-1) agonists in each application, can be divided into

Hospital

Pharmacy

Application 3

Table of Contents

Global Glucagon like peptide-1 (GLP-1) agonists Market Research Report 2016

1 Glucagon like peptide-1 (GLP-1) agonists Market Overview

1.1 Product Overview and Scope of Glucagon like peptide-1 (GLP-1) agonists

1.2 Glucagon like peptide-1 (GLP-1) agonists Segment by Type

1.2.1 Global Production Market Share of Glucagon like peptide-1 (GLP-1) agonists by Type in 2015

1.2.2 Exenatied

1.2.3 Liraglutide

1.2.4 Lixisenatide

1.2.5 Abliglutide

1.2.6 Dulaglutide

1.3 Glucagon like peptide-1 (GLP-1) agonists Segment by Application

1.3.1 Glucagon like peptide-1 (GLP-1) agonists Consumption Market Share by Application in 2015

1.3.2 Hospital

1.3.3 Pharmacy

1.3.4 Application 3

1.4 Glucagon like peptide-1 (GLP-1) agonists Market by Region

1.4.1 North America Status and Prospect (2011-2021)

1.4.2 Europe Status and Prospect (2011-2021)

1.4.3 China Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 Southeast Asia Status and Prospect (2011-2021)

1.4.6 India Status and Prospect (2011-2021)

1.5 Global Market Size (Value) of Glucagon like peptide-1 (GLP-1) agonists (2011-2021)

2 Global Glucagon like peptide-1 (GLP-1) agonists Market Competition by Manufacturers

2.1 Global Glucagon like peptide-1 (GLP-1) agonists Production and Share by Manufacturers (2015 and 2016)

2.2 Global Glucagon like peptide-1 (GLP-1) agonists Revenue and Share by Manufacturers (2015 and 2016)

2.3 Global Glucagon like peptide-1 (GLP-1) agonists Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Glucagon like peptide-1 (GLP-1) agonists Manufacturing Base Distribution, Sales Area and Product Type

2.5 Glucagon like peptide-1 (GLP-1) agonists Market Competitive Situation and Trends

2.5.1 Glucagon like peptide-1 (GLP-1) agonists Market Concentration Rate

2.5.2 Glucagon like peptide-1 (GLP-1) agonists Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Glucagon like peptide-1 (GLP-1) agonists Production, Revenue (Value) by Region (2011-2016)

3.1 Global Glucagon like peptide-1 (GLP-1) agonists Production and Market Share by Region (2011-2016)

3.2 Global Glucagon like peptide-1 (GLP-1) agonists Revenue (Value) and Market Share by Region (2011-2016)

3.3 Global Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

3.4 North America Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

3.5 Europe Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

3.6 China Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

3.7 Japan Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

3.8 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

3.9 India Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Glucagon like peptide-1 (GLP-1) agonists Supply (Production), Consumption, Export, Import by Regions (2011-2016)

4.1 Global Glucagon like peptide-1 (GLP-1) agonists Consumption by Regions (2011-2016)

4.2 North America Glucagon like peptide-1 (GLP-1) agonists Production, Consumption, Export, Import by Regions (2011-2016)

4.3 Europe Glucagon like peptide-1 (GLP-1) agonists Production, Consumption, Export, Import by Regions (2011-2016)

4.4 China Glucagon like peptide-1 (GLP-1) agonists Production, Consumption, Export, Import by Regions (2011-2016)

4.5 Japan Glucagon like peptide-1 (GLP-1) agonists Production, Consumption, Export, Import by Regions (2011-2016)

4.6 Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Production, Consumption, Export, Import by Regions (2011-2016)

4.7 India Glucagon like peptide-1 (GLP-1) agonists Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Glucagon like peptide-1 (GLP-1) agonists Production, Revenue (Value), Price Trend by Type

5.1 Global Glucagon like peptide-1 (GLP-1) agonists Production and Market Share by Type (2011-2016)

5.2 Global Glucagon like peptide-1 (GLP-1) agonists Revenue and Market Share by Type (2011-2016)

5.3 Global Glucagon like peptide-1 (GLP-1) agonists Price by Type (2011-2016)

5.4 Global Glucagon like peptide-1 (GLP-1) agonists Production Growth by Type (2011-2016)

6 Global Glucagon like peptide-1 (GLP-1) agonists Market Analysis by Application

6.1 Global Glucagon like peptide-1 (GLP-1) agonists Consumption and Market Share by Application (2011-2016)

6.2 Global Glucagon like peptide-1 (GLP-1) agonists Consumption Growth Rate by Application (2011-2016)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Glucagon like peptide-1 (GLP-1) agonists Manufacturers Profiles/Analysis

7.1 Novo Nordisk

7.1.1 Company Basic Information, Manufacturing Base and Its Competitors

7.1.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification

7.1.2.1 Type I

7.1.2.2 Type II

7.1.3 Novo Nordisk Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2015 and 2016)

7.1.4 Main Business/Business Overview

7.2 AstraZeneca

7.2.1 Company Basic Information, Manufacturing Base and Its Competitors

7.2.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification

7.2.2.1 Type I

7.2.2.2 Type II

7.2.3 AstraZeneca Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2015 and 2016)

7.2.4 Main Business/Business Overview

7.3 Eli Lilly

7.3.1 Company Basic Information, Manufacturing Base and Its Competitors

7.3.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification

7.3.2.1 Type I

7.3.2.2 Type II

7.3.3 Eli Lilly Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2015 and 2016)

7.3.4 Main Business/Business Overview

7.4 GSK

7.4.1 Company Basic Information, Manufacturing Base and Its Competitors

7.4.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification

7.4.2.1 Type I

7.4.2.2 Type II

7.4.3 GSK Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2015 and 2016)

7.4.4 Main Business/Business Overview

7.5 Sanofi

7.5.1 Company Basic Information, Manufacturing Base and Its Competitors

7.5.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification

7.5.2.1 Type I

7.5.2.2 Type II

7.5.3 Sanofi Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2015 and 2016)

7.5.4 Main Business/Business Overview

7.6 Bristol-Myers Squibb

7.6.1 Company Basic Information, Manufacturing Base and Its Competitors

7.6.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification

7.6.2.1 Type I

7.6.2.2 Type II

7.6.3 Bristol-Myers Squibb Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2015 and 2016)

7.6.4 Main Business/Business Overview

7.7 Amylin

7.7.1 Company Basic Information, Manufacturing Base and Its Competitors

7.7.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification

7.7.2.1 Type I

7.7.2.2 Type II

7.7.3 Amylin Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2015 and 2016)

7.7.4 Main Business/Business Overview

...

8 Glucagon like peptide-1 (GLP-1) agonists Manufacturing Cost Analysis

8.1 Glucagon like peptide-1 (GLP-1) agonists Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Glucagon like peptide-1 (GLP-1) agonists

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Glucagon like peptide-1 (GLP-1) agonists Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Glucagon like peptide-1 (GLP-1) agonists Market Forecast (2016-2021)

12.1 Global Glucagon like peptide-1 (GLP-1) agonists Production, Revenue Forecast (2016-2021)

12.2 Global Glucagon like peptide-1 (GLP-1) agonists Production, Consumption Forecast by Regions (2016-2021)

12.3 Global Glucagon like peptide-1 (GLP-1) agonists Production Forecast by Type (2016-2021)

12.4 Global Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast by Application (2016-2021)

12.5 Glucagon like peptide-1 (GLP-1) agonists Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

List of Tables and Figures

Figure Picture of Glucagon like peptide-1 (GLP-1) agonists

Figure Global Production Market Share of Glucagon like peptide-1 (GLP-1) agonists by Type in 2015

Figure Product Picture of Exenatied

Table Major Manufacturers of Exenatied

Figure Product Picture of Liraglutide

Table Major Manufacturers of Liraglutide

Figure Product Picture of Lixisenatide

Table Major Manufacturers of Lixisenatide

Figure Product Picture of Abliglutide

Table Major Manufacturers of Abliglutide

Figure Product Picture of Dulaglutide

Table Major Manufacturers of Dulaglutide

Table Glucagon like peptide-1 (GLP-1) agonists Consumption Market Share by Application in 2015

Figure Hospital Examples

Figure Pharmacy Examples

Figure Application 3 Examples

Figure North America Glucagon like peptide-1 (GLP-1) agonists Revenue (Million USD) and Growth Rate (2011-2021)

Figure Europe Glucagon like peptide-1 (GLP-1) agonists Revenue (Million USD) and Growth Rate (2011-2021)

Figure China Glucagon like peptide-1 (GLP-1) agonists Revenue (Million USD) and Growth Rate (2011-2021)

Figure Japan Glucagon like peptide-1 (GLP-1) agonists Revenue (Million USD) and Growth Rate (2011-2021)

Figure Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Revenue (Million USD) and Growth Rate (2011-2021)

Figure India Glucagon like peptide-1 (GLP-1) agonists Revenue (Million USD) and Growth Rate (2011-2021)

Figure Global Glucagon like peptide-1 (GLP-1) agonists Revenue (Million UDS) and Growth Rate (2011-2021)

Table Global Glucagon like peptide-1 (GLP-1) agonists Production of Key Manufacturers (2015 and 2016)

Table Global Glucagon like peptide-1 (GLP-1) agonists Production Share by Manufacturers (2015 and 2016)

Figure 2015 Glucagon like peptide-1 (GLP-1) agonists Production Share by Manufacturers

Figure 2016 Glucagon like peptide-1 (GLP-1) agonists Production Share by Manufacturers

Table Global Glucagon like peptide-1 (GLP-1) agonists Revenue (Million USD) by Manufacturers (2015 and 2016)

Table Global Glucagon like peptide-1 (GLP-1) agonists Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global Glucagon like peptide-1 (GLP-1) agonists Revenue Share by Manufacturers

Table 2016 Global Glucagon like peptide-1 (GLP-1) agonists Revenue Share by Manufacturers

Table Global Market Glucagon like peptide-1 (GLP-1) agonists Average Price of Key Manufacturers (2015 and 2016)

Figure Global Market Glucagon like peptide-1 (GLP-1) agonists Average Price of Key Manufacturers in 2015

Table Manufacturers Glucagon like peptide-1 (GLP-1) agonists Manufacturing Base Distribution and Sales Area

Table Manufacturers Glucagon like peptide-1 (GLP-1) agonists Product Type

Figure Glucagon like peptide-1 (GLP-1) agonists Market Share of Top 3 Manufacturers

Figure Glucagon like peptide-1 (GLP-1) agonists Market Share of Top 5 Manufacturers

Table Global Glucagon like peptide-1 (GLP-1) agonists Production by Regions (2011-2016)

Figure Global Glucagon like peptide-1 (GLP-1) agonists Production and Market Share by Regions (2011-2016)

Figure Global Glucagon like peptide-1 (GLP-1) agonists Production Market Share by Regions (2011-2016)

Figure 2015 Global Glucagon like peptide-1 (GLP-1) agonists Production Market Share by Regions

Table Global Glucagon like peptide-1 (GLP-1) agonists Revenue by Regions (2011-2016)

Table Global Glucagon like peptide-1 (GLP-1) agonists Revenue Market Share by Regions (2011-2016)

Table 2015 Global Glucagon like peptide-1 (GLP-1) agonists Revenue Market Share by Regions

Table Global Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

Table North America Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

Table Europe Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

Table China Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

Table Japan Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

Table Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

Table India Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

Table Global Glucagon like peptide-1 (GLP-1) agonists Consumption Market by Regions (2011-2016)

Table Global Glucagon like peptide-1 (GLP-1) agonists Consumption Market Share by Regions (2011-2016)

Figure Global Glucagon like peptide-1 (GLP-1) agonists Consumption Market Share by Regions (2011-2016)

Figure 2015 Global Glucagon like peptide-1 (GLP-1) agonists Consumption Market Share by Regions

Table North America Glucagon like peptide-1 (GLP-1) agonists Production, Consumption, Import & Export (2011-2016)

Table Europe Glucagon like peptide-1 (GLP-1) agonists Production, Consumption, Import & Export (2011-2016)

Table China Glucagon like peptide-1 (GLP-1) agonists Production, Consumption, Import & Export (2011-2016)

Table Japan Glucagon like peptide-1 (GLP-1) agonists Production, Consumption, Import & Export (2011-2016)

Table Southeast Asia Glucagon like peptide-1 (GLP-1) agonists Production, Consumption, Import & Export (2011-2016)

Table India Glucagon like peptide-1 (GLP-1) agonists Production, Consumption, Import & Export (2011-2016)

Table Global Glucagon like peptide-1 (GLP-1) agonists Production by Type (2011-2016)

Table Global Glucagon like peptide-1 (GLP-1) agonists Production Share by Type (2011-2016)

Figure Production Market Share of Glucagon like peptide-1 (GLP-1) agonists by Type (2011-2016)

Figure 2015 Production Market Share of Glucagon like peptide-1 (GLP-1) agonists by Type

Table Global Glucagon like peptide-1 (GLP-1) agonists Revenue by Type (2011-2016)

Table Global Glucagon like peptide-1 (GLP-1) agonists Revenue Share by Type (2011-2016)

Figure Production Revenue Share of Glucagon like peptide-1 (GLP-1) agonists by Type (2011-2016)

Figure 2015 Revenue Market Share of Glucagon like peptide-1 (GLP-1) agonists by Type

Table Global Glucagon like peptide-1 (GLP-1) agonists Price by Type (2011-2016)

Figure Global Glucagon like peptide-1 (GLP-1) agonists Production Growth by Type (2011-2016)

Table Global Glucagon like peptide-1 (GLP-1) agonists Consumption by Application (2011-2016)

Table Global Glucagon like peptide-1 (GLP-1) agonists Consumption Market Share by Application (2011-2016)

Figure Global Glucagon like peptide-1 (GLP-1) agonists Consumption Market Share by Application in 2015

Table Global Glucagon like peptide-1 (GLP-1) agonists Consumption Growth Rate by Application (2011-2016)

Figure Global Glucagon like peptide-1 (GLP-1) agonists Consumption Growth Rate by Application (2011-2016)

Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novo Nordisk Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

Figure Novo Nordisk Glucagon like peptide-1 (GLP-1) agonists Market Share (2011-2016)

Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table AstraZeneca Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

Figure AstraZeneca Glucagon like peptide-1 (GLP-1) agonists Market Share (2011-2016)

Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Eli Lilly Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

Figure Eli Lilly Glucagon like peptide-1 (GLP-1) agonists Market Share (2011-2016)

Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table GSK Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

Figure GSK Glucagon like peptide-1 (GLP-1) agonists Market Share (2011-2016)

Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Sanofi Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

Figure Sanofi Glucagon like peptide-1 (GLP-1) agonists Market Share (2011-2016)

Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bristol-Myers Squibb Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

Figure Bristol-Myers Squibb Glucagon like peptide-1 (GLP-1) agonists Market Share (2011-2016)

Table Amylin Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Amylin Glucagon like peptide-1 (GLP-1) agonists Production, Revenue, Price and Gross Margin (2011-2016)

Figure Amylin Glucagon like peptide-1 (GLP-1) agonists Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Glucagon like peptide-1 (GLP-1) agonists

Figure Manufacturing Process Analysis of Glucagon like peptide-1 (GLP-1) agonists

Figure Glucagon like peptide-1 (GLP-1) agonists Industrial Chain Analysis

Table Raw Materials Sources of Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015

Table Major Buyers of Glucagon like peptide-1 (GLP-1) agonists

Table Distributors/Traders List

Figure Global Glucagon like peptide-1 (GLP-1) agonists Production and Growth Rate Forecast (2016-2021)

Figure Global Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate Forecast (2016-2021)

Table Global Glucagon like peptide-1 (GLP-1) agonists Production Forecast by Regions (2016-2021)

Table Global Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast by Regions (2016-2021)

Table Global Glucagon like peptide-1 (GLP-1) agonists Production Forecast by Type (2016-2021)

Table Global Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370